After treatment, many patients live long, full lives free from the effects of myocarditis. For others, however, ongoing cardiovascular medication or even a heart transplant may be needed. Overall, dilated…
Dr. Dor Lotan is an Assistant Professor of Cardiology and Advanced Heart Failure, Mechanical Circulatory Support and Transplant Cardiologist at Columbia University Irving Medical Center, NYC. Recently, he has been…
As we have said in the past, information on COVID-19 vaccines remains a very fluid situation. As time goes on, more and more is learned about the vaccines and any…
On a rainy March day in Baltimore, 100 cardiovascular pathologists and cardiologists, from around the world, met in person or virtually to discuss myocarditis. The event was the culmination of…
The EveryLife Foundation for Rare Diseases established the #Rareis Scholarship Fund for anyone over the age of 17, resident of the United States and diagnosed with a rare disease (such as myocarditis).…
The Myocarditis Foundation is thrilled to announce the dates of our 2024 family meeting! This family meeting will be held July 11th through July 14th in Dallas, Texas, at the…
Dr. Leslie Cooper recently had a paper published in “Circulation”, an American Heart Association Journal, on “Myocarditis: Entering the Mainstream”. Read about the first description of myocarditis in 1837, to the…
In 1986, a group of 8 cardiac pathologists (who were known as the Dallas Panel), made an attempt to establish uniform criteria for the diagnosis of myocarditis in heart biopsy…
As Rare Disease Day approaches on February 29th, it’s a moment for reflection, awareness, and most importantly, unity. In the vast landscape of medical conditions, some are so rare that…
Due to the Pre-Clinical Data and Initial Clinical Data from Cardiol’s Maverick-Pilot Phase II Study of Pericarditis, it has been granted Orphan Drug Designation for its lead drug candidate for…
